MedTrace Logo

The Influence of Testosterone on Experimental Pain Perception

NCT05781685 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-08-05

Study results available
· View outcomes & findings →

Summary

This trial examined how the administration of exogenous testosterone would influence pain tolerance and other endogenous steroids (i.e. estradiol and progesterone).

Conditions

  • Acute Pain

Interventions

DRUG

Testosterone

Sublingual testosterone was administered to participants. Participants would self-administer the testosterone to themselves.

OTHER

Placebo Syrup

Oil-based sublingual product.

Sponsors & Collaborators

  • American Psychological Association (APA)

    collaborator OTHER

  • University of New Mexico

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2018-07-17
Completion
2018-07-17
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05781685 on ClinicalTrials.gov